Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Meessen

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 10, 2021
Reply: Applicability of ISCHEMIA in real-world practice: where to START?Leonardo De Luca, Jennifer Meessen
Critical Care Medicine|August 17, 2018
The authors replyHelge Røsjø, Pietro Caironi, Jennifer Meessen, et al.
Clinical Biochemistry|June 5, 2023
Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trialHelge Røsjø, Jennifer Meessen, Anett Hellebø Ottesen, et al.
Cells|February 25, 2022
Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE StudyFederico Carbone, Jennifer Meessen, Marco Magnoni, et al.
European Journal of Clinical Investigation|March 4, 2021
Circulating pentraxin 3 in severe COVID-19 or other pulmonary sepsisAlessandro Protti, Jennifer Meessen, Barbara Bottazzi, et al.
Clinical Cardiology|September 1, 2019
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI StudyLeonardo De Luca, Furio Colivicchi, Jennifer Meessen, et al.
American Heart Journal|June 2, 2024
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50Lee B Bockus, Ramin Shadman, Jeanne E Poole, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 11, 2021
Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registryLeonardo De Luca, Michele M Gulizia, Domenico Gabrielli, et al.
International Journal of Cardiology|May 30, 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registryLeonardo De Luca, Marcello Arca, Pier Luigi Temporelli, et al.
Frontiers in Oncology|February 13, 2023
Brain tumours in the time of COVID-19: An online survey on patients' disease experience in one Italian regionGiorgia Abete-Fornara, Francesca Mameli, Fabiana Ruggiero, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 10, 2021
Reply: Applicability of ISCHEMIA in real-world practice: where to START?Leonardo De Luca, Jennifer Meessen
Critical Care Medicine|August 17, 2018
The authors replyHelge Røsjø, Pietro Caironi, Jennifer Meessen, et al.
Clinical Biochemistry|June 5, 2023
Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trialHelge Røsjø, Jennifer Meessen, Anett Hellebø Ottesen, et al.
Cells|February 25, 2022
Osteopontin as Candidate Biomarker of Coronary Disease despite Low Cardiovascular Risk: Insights from CAPIRE StudyFederico Carbone, Jennifer Meessen, Marco Magnoni, et al.
European Journal of Clinical Investigation|March 4, 2021
Circulating pentraxin 3 in severe COVID-19 or other pulmonary sepsisAlessandro Protti, Jennifer Meessen, Barbara Bottazzi, et al.
Clinical Cardiology|September 1, 2019
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI StudyLeonardo De Luca, Furio Colivicchi, Jennifer Meessen, et al.
American Heart Journal|June 2, 2024
Seattle proportional risk model in GISSI-HF: Estimated benefit of ICD in patients with EF less than 50Lee B Bockus, Ramin Shadman, Jeanne E Poole, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 11, 2021
Impact of serum uric acid levels on cardiovascular events and quality of life in patients with chronic coronary syndromes: Insights from a contemporary, prospective, nationwide registryLeonardo De Luca, Michele M Gulizia, Domenico Gabrielli, et al.
International Journal of Cardiology|May 30, 2020
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registryLeonardo De Luca, Marcello Arca, Pier Luigi Temporelli, et al.
Frontiers in Oncology|February 13, 2023
Brain tumours in the time of COVID-19: An online survey on patients' disease experience in one Italian regionGiorgia Abete-Fornara, Francesca Mameli, Fabiana Ruggiero, et al.
Pageof 4